We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+13.92%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.07B
AUM Growth
+$131M
Cap. Flow
-$8.41M
Cap. Flow %
-0.41%
Top 10 Hldgs %
17.49%
Holding
270
New
21
Increased
72
Reduced
124
Closed
24

Sector Composition

1 Healthcare 30.79%
2 Industrials 15.85%
3 Consumer Discretionary 14.25%
4 Technology 13.06%
5 Financials 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMCI icon
1
Super Micro Computer
SMCI
$15.6B
$40.4M 1.95%
4,924,150
-1,075,480
-18% -$8.19M
SMPL icon
2
Simply Good Foods
SMPL
$980M
$40.2M 1.94%
1,057,790
-94,540
-8% -$3.49M
MTSI icon
3
MACOM Technology Solutions
MTSI
$20.4B
$37.9M 1.83%
601,560
-89,996
-13% -$5.62M
CHDN icon
4
Churchill Downs
CHDN
$5.85B
$37.7M 1.82%
356,194
+238
+0.1% +$25.1K
MMSI icon
5
Merit Medical Systems
MMSI
$4.41B
$36.9M 1.78%
522,170
-10,144
-2% -$677K
WHD icon
6
Cactus
WHD
$3.78B
$34.8M 1.68%
692,817
-4,683
-0.7% -$235K
TMDX icon
7
Transmedics
TMDX
$2.56B
$34.7M 1.68%
562,667
+67,741
+14% +$3.6M
NVEE
8
DELISTED
NV5 Global
NVEE
$34.2M 1.65%
1,033,192
-3,828
-0.4% -$133K
PLNT icon
9
Planet Fitness
PLNT
$4.14B
$32.9M 1.59%
417,736
+2,055
+0.5% +$143K
REPL icon
10
Replimune Group
REPL
$859M
$32.3M 1.56%
1,186,041
+49,455
+4% +$1.03M
AMLX icon
11
Amylyx Pharmaceuticals
AMLX
$1.97B
$30.9M 1.49%
836,909
+235,683
+39% +$8.36M
FOUR icon
12
Shift4
FOUR
$3.99B
$30.7M 1.48%
548,368
-2,277
-0.4% -$108K
EYE icon
13
National Vision
EYE
$1.66B
$30.2M 1.46%
780,303
-5,091
-0.6% -$191K
MODN
14
DELISTED
MODEL N, INC.
MODN
$29.2M 1.41%
719,600
-3,162
-0.4% -$119K
EVRI
15
DELISTED
Everi Holdings
EVRI
$29.1M 1.4%
2,025,278
-23,156
-1% -$385K
MC icon
16
Moelis & Co
MC
$5.02B
$28.2M 1.36%
734,692
+66,078
+10% +$2.68M
FRPT icon
17
Freshpet
FRPT
$2.78B
$28.2M 1.36%
534,118
+6,448
+1% +$384K
BWIN
18
Baldwin Insurance Group
BWIN
$2.66B
$28.1M 1.36%
1,117,009
-19,545
-2% -$538K
PRFT
19
DELISTED
Perficient Inc
PRFT
$28.1M 1.36%
401,691
-3,288
-0.8% -$227K
TMCI icon
20
Treace Medical Concepts
TMCI
$279M
$27.3M 1.32%
1,188,246
+67,481
+6% +$1.55M
PPBI
21
DELISTED
Pacific Premier Bancorp
PPBI
$26.7M 1.29%
846,099
-180,677
-18% -$6.22M
EXPO icon
22
Exponent
EXPO
$3.05B
$26.5M 1.28%
267,938
+668
+0.2% +$64.9K
UTHR icon
23
United Therapeutics
UTHR
$22.7B
$26.3M 1.27%
94,442
+1,189
+1% +$300K
NOG icon
24
Northern Oil and Gas
NOG
$2.31B
$26.2M 1.27%
849,722
+158,420
+23% +$5.33M
ACDC icon
25
ProFrac Holding
ACDC
$868M
$26.1M 1.26%
1,036,375
-145,556
-12% -$3.22M

Similar funds

Emerald Advisers's Q4 2022 Portfolio in Review

As of Q4 2022, Emerald Advisers held 270 positions worth $2.07B, up 6.8% from $1.94B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Emerald Advisers's Q4 2022 filing shows 21 new, 72 increased, 124 reduced and 24 closed positions. Its largest new stake was Insmed: 994,913 shares worth $19.9M. The largest sale was Integer Holdings, an estimated $17.9M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Emerald Advisers's largest Q4 2022 buy was Insmed: 994,913 shares worth $19.9M.
  • Emerald Advisers added most to Evoqua Water Technologies Corp. Common Stock in Q4 2022, an estimated $11.6M increase.
  • Emerald Advisers's biggest Q4 2022 reduction was Integer Holdings, cutting an estimated $17.9M.
  • Emerald Advisers fully exited Tandem Diabetes Care in Q4 2022, selling an estimated $14.3M.
  • Emerald Advisers's ten largest holdings make up 17% of its $2.07B portfolio in Q4 2022.
  • Emerald Advisers opened 21 new positions and closed 24 in Q4 2022.
  • Emerald Advisers's portfolio value rose 6.8% quarter-over-quarter to $2.07B.

Based on Emerald Advisers's 13F filing for Q4 2022, filed 3 Feb 2023.